Neil Herskowitz sold $46 of ATXI
director at AVENUE THERAPEUTICS, INC.. 23 shares at an average of $2.00, traded Dec 2, 2024, filed Dec 3, 2024.
Score components
- +15RoleDirector
- 0Trade size$46 at market
- +5Share of holdings soldSold 19% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +3.2%, 3m -46.5%, 6m -86.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-24-125093, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 2, 2024 | SOpen-market sale COMMON STOCK, PAR VALUE $0.0001 | -23 | $2.00 | $46 | 97 | Dec 3, 2024 |
Related signals
Other insiders at AVENUE THERAPEUTICS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | ATXIsell AVENUE THERAPEUTICS, INC. | Jay D Kranzler director | $137 61 shares | -10% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.